Response to nutritional and growth hormone treatment in progeria

Metabolism: Clinical and Experimental

Volumn 46, Issue 8, 1997, Pages 851-856

  Abdenur, Jose E ^a   Brown, W Ted ^b   Friedman, Silvia ^c   Smith, Melanie ^c   Lifshitz, Fima ^c  

^a Fund Estud Enferm N   (Argentina)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; BASAL METABOLIC RATE; CHILD; CLINICAL ARTICLE; DIET THERAPY; FAILURE TO THRIVE; FEMALE; GROWTH DISORDER; GROWTH RATE; HORMONAL THERAPY; HORMONE RESISTANCE; HORMONE RESPONSE; HUMAN; MALE; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROGERIA; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0030756139     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90069-X     Document Type: Article

References (42)

1. DeBusk FL: The Hutchinson-Gilford progeria syndrome. J Pediatr 80:697-724, 1972
2. Brown WT, Zebrower M, Kieras FJ: Progeria: A genetic disease model of premature aging, in Harrison DE (ed): Genetic Effects on Aging, vol 2. Caldwell, NJ, Telford, 1991, pp 521-542
3. Brown WT, Kieras FJ, Houck GE, et al: A comparison of adult and childhood progerias: Werner syndrome and Hutchinson-Gilford progeria syndrome. Adv Exp Med Biol 190:229-244, 1985
4. Baker PB, Baba N, Boesel CP: Cardiovascular abnormalities in progeria. Arch Pathol Lab Med 105:384-386, 1981
5. Smith WS, Wiznitzer M, Karaman BA, et al: MRA detection of vascular occlusion in a child with progeria. AJNR Am J Neuroradiol 14:441-443, 1993
6. McCandless BK, Cooper JA: Myocardial perfusion imaging with pharmacologic stress in a 9-year-old girl. Clin Nucl Med 19:344-345, 1994
7. Kieras FJ, Brown WT, Houck GE, et al: Elevation of urinary hyaluronic acid in Werner syndrome and progeria. Biochem Med Metab Biol 36:276-282, 1985
8. Jones K, Smith P, Harvey M, et al: Older paternal age and fresh gene mutation: Data on additional disorders. J Pediatr 86:84-88, 1975
9. Villee DB, Nichols G, Talbot NB: Metabolic studies in two boys with classical progeria. Pediatrics 43:207-216, 1969
10. Rosenbloom AL, Karacan IJ, DeBusk FL: Sleep characteristics and endocrine response in progeria. J Pediatr 77:692-695, 1970
11. Rosenbloom AL, Kappy MS, DeBusk FL, et al: Progeria: Insulin resistance and hyperglycemia. J Pediatr 102:400-402, 1983
12. Harley CB, Goldstein S, Posner BI, et al: Decreased sensitivity of old and progeric human fibroblasts to a preparation of factors with insulin like activity. J Clin Invest 68:988-994, 1981
13. Conover CA, Dollar LA, Rosenfeld RG, et al: Somatomedin C-binding and action in fibroblasts from aged and progeric subjects. J Clin Endocrinol Metab 60:685-691, 1985
14. Rosenbloom AL, Goldstein S, Yip CC: Insulin binding to cultured human fibroblasts increases with normal and precocious aging. Science 193:412-415, 1976
15. Talbot NB, Butler AM, Pratt EL, et al: Progeria: Clinical metabolic and pathologic studies on a patient. Am J Dis Child 69:267-279, 1945
16. Hasty MF, Vann WF: Progeria in a pediatric dental patient: Literature review and case report. Pediatr Dent 10:314-319, 1988
17. Ginsberg LJ: A practical approach to tolerance testing in children, in Lifshitz F (ed): Pediatric Endocrinology (ed 2). New York, NY, Dekker, 1990, pp 953-982
18. Tanner JM, Davies PSW: Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 107:312-329, 1985
19. Jordan MD: Centers for Disease Control Anthropometric Softward Package (CASP), version 3.0. Atlanta, GA, Centers for Disease Control, 1987
20. Tanner JM: Growth at Adolescence (ed 2). Oxford, UK, Blackwell Scientific, 1962
21. Tanner JM, Whitehouse RH, Marshall WA, et al: Assessment of skeletal maturity and prediction of adult height. London, UK, Academic, 1975
22. Veldhuis JD, Johnson ML: A novel general biophysical model for simulating episodic endocrine gland signaling. Am J Physiol 255:E740-E759, 1988
23. Abdenur JE, Pugliese MT, Cervantes C, et al: Alterations in spontaneous growth hormone secretion and the response to growth hormone releasing hormone in children with non organic nutritional dwarfing. J Clin Endocrinol Metab 75:930-934, 1992
24. Srikanta S, Ganda OP, Gleason RE, et al: Pre-type I diabetes: Linear loss of beta cell response to intravenous glucose. Diabetes 33:717-720, 1984
25. Conzolazio CF, Johnson RE, Pecora LJ: Physiological Measurements of Metabolic Functions in Man. New York, NY, McGraw-Hill, 1963
26. Weir JB: New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109:1-9, 1949
27. Friedman S, Smith M, Shih-Yu Lee P, et al: Energy metabolism and fuel utilization in nutritional dwarfing children. J Am Coll Nutr 10:A61, 1991 (abstr)
28. Burnstein S, Glaser P, Trichet B, et al: Utilization of protein, carbohydrates and fat in fasting and post absorptive subjects. Am J Clin Nutr 33:998-1001, 1980
29. +ATPaSe activity. Am J Clin Nutr 54:997-1004, 1991
30. Frisancho AR: New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 34:2540-2545, 1981
31. Rossouw JE: Kwashiorkor in North America. Am J Clin Nutr 49:588-592, 1989
32. MacLean WC Jr: Protein energy malnutrition, in Grand R, Sutphen JL, Dietz WH (eds): Pediatric Nutrition: Theory and Practice. Boston, MA, Butterworth, 1987, pp 421-431
33. Winick M, Rosso P: Head circumference and cellular growth of the brain in normal and marasmic children. J Pediatr 74:774-778, 1969
34. Galler JR, Ramsey FC, Morley DS, et al: The long-term effects of early kwashiorkor compared with marasmus. IV. Performance on the National High School Entrance Examination. Pediatr Res 28:235-239, 1990
35. Kerr DS, Stevens MCG, Robinson HM: Fasting metabolism in infants. Effect of severe undernutrition on energy and protein utilization. Metabolism 27:411-435, 1978
36. Parra A, Garza C, Garza Y, et al: Changes in growth hormone, insulin and thyroxine values and in energy metabolism of marasmatic children. J Pediatr 83:133-142, 1973
37. Underwood LE, Clemmons DR, Maes M, et al: Regulation of somatomedin-C by nutrients. Horm Res 24:166-176, 1986
38. Laron Z, Blum W, Chatelain P, et al: Classification of growth hormone insensitivity syndrome. J Pediatr 122:241, 1993
39. Abdenur J, Vaquero Solans C, Smith M, et al: Body composition and spontaneous growth hormone secretion in normal children with short stature. J Clin Endocrinol Metab 78:277-282, 1994
40. Walker JM, Bond SA, Voss LD, et al: Treatment of short normal children with growth hormone: A cautionary tale? Lancet 336:1331-1334, 1990
41. Blackman MR: Aging and endocrinology, in Becker KL (ed): Principles and Practice of Endocrinology and Metabolism. Philadelphia, PA, Lippincott, 1990, pp 1461-1471
42. Walker J, Chaussain JL, Bougneres PF: Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal. J Clin Endocrinol Metab 69:253-258, 1989